These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17584025)

  • 1. Targeting the leukemia microenvironment.
    Konopleva M; Andreeff M
    Curr Drug Targets; 2007 Jun; 8(6):685-701. PubMed ID: 17584025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.
    Konopleva M; Tabe Y; Zeng Z; Andreeff M
    Drug Resist Updat; 2009; 12(4-5):103-13. PubMed ID: 19632887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the bone marrow microenvironment in hematologic malignancies.
    Dalton WS; Hazlehurst L; Shain K; Landowski T; Alsina M
    Semin Hematol; 2004 Apr; 41(2 Suppl 4):1-5. PubMed ID: 15190509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
    Zanetti C; Krause DS
    Exp Hematol; 2020 Sep; 89():13-25. PubMed ID: 32755619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bone marrow adipocytes in leukemia and chemotherapy challenges.
    Samimi A; Ghanavat M; Shahrabi S; Azizidoost S; Saki N
    Cell Mol Life Sci; 2019 Jul; 76(13):2489-2497. PubMed ID: 30715556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia Stem Cells Microenvironment.
    Tabe Y; Konopleva M
    Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of bone microenvironment to leukemogenesis and leukemia progression.
    Ayala F; Dewar R; Kieran M; Kalluri R
    Leukemia; 2009 Dec; 23(12):2233-41. PubMed ID: 19727127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnosis of and molecular targeting therapy for leukemia].
    Tabe Y
    Rinsho Byori; 2009 Feb; 57(2):137-45. PubMed ID: 19317219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone marrow microenvironment in health and disease at a glance.
    Kumar R; Godavarthy PS; Krause DS
    J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29472498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
    Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M
    Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Chemotherapy Resistant Leukemia In Vitro.
    Slone WL; Moses BS; Evans R; Piktel D; Martin KH; Petros W; Craig M; Gibson LF
    J Vis Exp; 2016 Feb; (108):e53645. PubMed ID: 26891147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia.
    Yamaguchi T; Kawamoto E; Gaowa A; Park EJ; Shimaoka M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Waterloo': when normal blood cells meet leukemia.
    Cheng H; Cheng T
    Curr Opin Hematol; 2016 Jul; 23(4):304-10. PubMed ID: 27115340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.
    Barbieri F; Bajetto A; Thellung S; Würth R; Florio T
    Expert Opin Drug Discov; 2016 Nov; 11(11):1093-1109. PubMed ID: 27598329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in understanding the leukaemia microenvironment.
    Tabe Y; Konopleva M
    Br J Haematol; 2014 Mar; 164(6):767-78. PubMed ID: 24405087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104.
    Benito J; Shi Y; Szymanska B; Carol H; Boehm I; Lu H; Konoplev S; Fang W; Zweidler-McKay PA; Campana D; Borthakur G; Bueso-Ramos C; Shpall E; Thomas DA; Jordan CT; Kantarjian H; Wilson WR; Lock R; Andreeff M; Konopleva M
    PLoS One; 2011; 6(8):e23108. PubMed ID: 21853076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bone Marrow Niche - The Tumor Microenvironment That Ensures Leukemia Progression.
    Cardoso BA
    Adv Exp Med Biol; 2020; 1219():259-293. PubMed ID: 32130704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.